Schedule 13D ownership disclosure
KYTO BIOPHARMA INC
Security class unavailable · CUSIP: 501572101
Event date: 2018-02-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 85.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-18-001762
- Form type
- SC 13D
- Filer
- BENARROCH GEORGES
- CIK
- CIK 1051339
- Filed
- Feb 22, 2018
- Reporting period
- Feb 21, 2018
- Description
- Schedule 13D beneficial ownership